Sfoglia per Rivista  ONCOTARGET

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 1 a 20 di 53
Titolo Data di pubblicazione Autore(i) File
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 1-gen-2015 Lionetti, ; Marta, ; Barbieri, ; Marzia, ; Todoerti, ; Katia, ; Agnelli, ; Luca, ; Fabris, ; Sonia, ; Tonon, G; Segalla, ; Simona, ; Cifola, ; Ingrid, ; Pinatel, ; Eva, ; Tassone, ; Pierfrancesco, ; Musto, ; Pellegrino, ; Baldini, ; Luca, ; Neri, ; Antonino,
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue 1-gen-2016 Longo, Vito; Brunetti, Oronzo; Gnoni, Antonio; Cascinu, Stefano; Gasparini, Giampietro; Lorusso, Vito; Ribatti, Domenico; Silvestris, Nicola
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 1-gen-2017 Casadei Gardini, Andrea; Santini, Daniele; Aprile, Giuseppe; Silvestris, Nicola; Felli, Emanuele; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Marisi, Giorgia; Valgiusti, Martina; Passardi, Alessandro; Puzzoni, Marco; Silletta, Marianna; Brunetti, Oronzo; Cardellino, Giovanni Gerardo; Frassineti, Giovanni Luca; Scartozzi, Mario
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 1-gen-2017 Navarria, P; Pessina, F; Tomatis, S; Soffietti, R; Grimaldi, M; Lopci, E; Chiti, A; Leonetti, A; Casarotti, A; Rossi, M; Cozzi, L; Ascolese, Am; Simonelli, M; Marcheselli, S; Santoro, A; Clerici, E; Bello, L; Scorsetti, M
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 1-gen-2018 Ultimo, Simona; Zauli, Giorgio; Martelli, Alberto M.; Vitale, Marco; Mccubrey, James A.; Capitani, Silvano; Neri, Luca M.
Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition 1-gen-2014 Passacantilli, I; Capurso, G; Archibugi, L; Calabretta, S; Caldarola, S; Loreni, F; Delle Fave, G; Sette, C
Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cells 1-gen-2017 Bagnato, Paola; Castagnino, Alessia; Cortese, Katia; Bono, Maria; Grasso, Silvia; Bellese, Grazia; Daniele, Tiziana; Lundmark, Richard; Defilippi, Paola; Castagnola, Patrizio; Tacchetti, Carlo
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 1-gen-2016 Calura, ; Enrica, ; Bisognin, ; Andrea, ; Manzoni, ; Martina, ; Todoerti, ; Katia, ; Taiana, ; Elisa, ; Sales, ; Gabriele, ; Morgan, ; Gareth, J.; Tonon, G; Amodio, ; Nicola, ; Tassone, ; Pierfrancesco, ; Neri, ; Antonino, ; Agnelli, ; Luca, ; Romualdi, ; Chiara, ; Bortoluzzi, ; Stefania,
Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced hcc patients treated with sorafenib: Results from a retrospective analysis of the HCC-AVR group 1-gen-2016 Casadei Gardini, Andrea; Scarpi, Emanuela; Marisi, Giorgia; Foschi, Francesco Giuseppe; Donati, Gabriele; Giampalma, Emanuela; Faloppi, Luca
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study 1-gen-2017 Brandes, ; A., A.; Finocchiaro, ; Zagonel, ; Reni, M; Fabi, ; Caserta, ; Tosoni, ; Eoli, ; Lombardi, ; Clavarezza, ; Paccapelo, ; Bartolini, ; Cirillo, ; Agati, ; Franceschi,
Effects of repeated sprints training on fracture risk-associated miRNA 1-gen-2018 Sansoni, Veronica; Perego, Silvia; Vernillo, Gianluca; Barbuti, Andrea; Merati, Giampiero; La Torre, Antonio; Banfi, Giuseppe; Lombardi, Giovanni
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 1-gen-2016 Casadei Gardini, Andrea; Marisi, Giorgia; Faloppi, Luca; Scarpi, Emanuela; Foschi, Francesco Giuseppe; Iavarone, Massimo; Lauletta, Gianfranco; Corbelli, Jody; Valgiusti, Martina; Facchetti, Floriana; della Corte, Cristina; Neri, Luca Maria; Tamberi, Stefano; Cascinu, Stefano; Scartozzi, Mario; Amadori, Dino; Nanni, Oriana; Tenti, Elena; Ulivi, Paola; Frassineti, Giovanni Luca
FAS/FASL are dysregulated in chordoma and their loss-of-function impairs zebrafish notochord formation 1-gen-2014 Ferrari, L; Pistocchi, A; Libera, L; Boari, N; Mortini, Pietro; Bellipanni, G; Giordano, A; Cotelli, F; Riva, P.
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 1-gen-2017 Vitali, E; Boemi, I; Rosso, L; Cambiaghi, V; Novellis, P; Mantovani, G; Spada, A; Alloisio, M; Veronesi, G; Ferrero, S; Lania, Ag
Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 1-gen-2016 Campa, D; Pastore, M; Gentiluomo, M; Talar Wojnarowska, R; Kupcinskas, J; Malecka Panas, E; Neoptolemos, Jp; Niesen, W; Vodicka, P; Delle Fave, G; Bas Bueno de Mesquita, H; Gazouli, M; Pacetti, P; Di Leo, M; Ito, H; Klüter, H; Soucek, P; Corbo, V; Yamao, K; Hosono, S; Kaaks, R; Vashist, Y; Gioffreda, D; Strobel, O; Shimizu, Y; Dijk, F; Andriulli, A; Ivanauskas, A; Bugert, P; Tavano, F; Vodickova, L; Zambon, Cf; Lovecek, M; Landi, S; Key, Tj; Boggi, U; Pezzilli, R; Jamroziak, K; Mohelnikova Duchonova, B; Mambrini, A; Bambi, F; Busch, O; Pazienza, V; Valente, R; Theodoropoulos, G; Hackert, T; Capurso, G; Cavestro, GIULIA MARTINA; Pasquali, C; Basso, D; Sperti, C; Matsuo, K; Büchler, M; Khaw, Kt; Izbicki, J; Costello, E; Katzke, V; Michalski, C; Stepien, A; Rizzato, C; Canzian, F.
GD2 expression in breast cancer 1-gen-2017 Orsi, Giulia; Barbolini, Monica; Ficarra, G; Tazzioli, Giovanni; Manni, Paola; Petrachi, Tiziana; Mastrolia, Ilenia; Orvieto, E; Spano, Maria Carlotta; Prapa, Malvina; Kaleci, Shaniko; D'Amico, Roberto; Guarneri, V; Dieci, Mv; Cascinu, Stefano; Conte, P; Piacentini, Federico; Dominici, Massimo
The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia 1-gen-2016 Papakonstantinou, Nikos; Ntoufa, Stavroula; Chartomatsidou, Elisavet; Kotta, Konstantia; Agathangelidis, Andreas; Giassafaki, Lefki; Karamanli, Tzeni; Bele, Panagiota; Moysiadis, Theodoros; Baliakas, Panagiotis; Sutton, Lesley Ann; Stavroyianni, Niki; Anagnostopoulos, Achilles; Makris, Antonios M.; Ghia, PAOLO PROSPERO; Rosenquist, Richard; Stamatopoulos, Kostas
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma 1-gen-2017 Pellegrini, Laura; Xue, Jiaming; Larson, David; Pastorino, Sandra; Jube, Sandro; Forest, Kelly H.; Saad jube, Zeyana Salim; Napolitano, Andrea; Pagano, Ian; Negi, Vishal S.; Bianchi, MARCO EMILIO; Morris, Paul; Pass, Harvey I.; Gaudino, Giovanni; Carbone, Michele; Yang, Haining
Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells 1-gen-2016 Castagnola, Patrizio; Bellese, Grazia; Birocchi, Filippo; Gagliani Maria, Cristina; Tacchetti, Carlo; Cortesekatia,
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib 1-gen-2016 Gardini, Andrea Casadei; Scarpi, Emanuela; Faloppi, Luca; Scartozzi, Mario; Silvestris, Nicola; Santini, Daniele; de Stefano, Giorgio; Marisi, Giorgia; Negri, Francesca V.; Foschi, Francesco Giuseppe; Valgiusti, Martina; Ercolani, Giorgio; Frassineti, Giovanni Luca
Mostrati risultati da 1 a 20 di 53
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile